IL85560A - Pharmaceutical compositions containing an antidepressant of the structural type of 10,11-dihydrodibenzo(b,f)azepine,a dibenzo-(a,d)(1,4)cycloheptadiene and/or a 10,11-dihydro-benzo-(b,f)oxepine and a pyrolidinone derivative - Google Patents

Pharmaceutical compositions containing an antidepressant of the structural type of 10,11-dihydrodibenzo(b,f)azepine,a dibenzo-(a,d)(1,4)cycloheptadiene and/or a 10,11-dihydro-benzo-(b,f)oxepine and a pyrolidinone derivative

Info

Publication number
IL85560A
IL85560A IL85560A IL8556088A IL85560A IL 85560 A IL85560 A IL 85560A IL 85560 A IL85560 A IL 85560A IL 8556088 A IL8556088 A IL 8556088A IL 85560 A IL85560 A IL 85560A
Authority
IL
Israel
Prior art keywords
pyrolidinone
oxepine
dihydrodibenzo
cycloheptadiene
azepine
Prior art date
Application number
IL85560A
Other languages
English (en)
Other versions
IL85560A0 (en
Original Assignee
Boehringer Ingelheim Kg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Kg filed Critical Boehringer Ingelheim Kg
Publication of IL85560A0 publication Critical patent/IL85560A0/xx
Publication of IL85560A publication Critical patent/IL85560A/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4151,2-Diazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Psychiatry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Cosmetics (AREA)
  • Dental Preparations (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Pyrrole Compounds (AREA)
IL85560A 1987-02-27 1988-02-26 Pharmaceutical compositions containing an antidepressant of the structural type of 10,11-dihydrodibenzo(b,f)azepine,a dibenzo-(a,d)(1,4)cycloheptadiene and/or a 10,11-dihydro-benzo-(b,f)oxepine and a pyrolidinone derivative IL85560A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19873706399 DE3706399A1 (de) 1987-02-27 1987-02-27 Mittel mit antidepressiver wirkung

Publications (2)

Publication Number Publication Date
IL85560A0 IL85560A0 (en) 1988-08-31
IL85560A true IL85560A (en) 1991-12-12

Family

ID=6321945

Family Applications (1)

Application Number Title Priority Date Filing Date
IL85560A IL85560A (en) 1987-02-27 1988-02-26 Pharmaceutical compositions containing an antidepressant of the structural type of 10,11-dihydrodibenzo(b,f)azepine,a dibenzo-(a,d)(1,4)cycloheptadiene and/or a 10,11-dihydro-benzo-(b,f)oxepine and a pyrolidinone derivative

Country Status (14)

Country Link
US (2) US4931435A (xx)
EP (1) EP0280290B1 (xx)
JP (1) JPS63238019A (xx)
KR (1) KR880009647A (xx)
AT (1) ATE71300T1 (xx)
AU (1) AU605554B2 (xx)
CA (1) CA1317229C (xx)
DE (2) DE3706399A1 (xx)
DK (1) DK102988A (xx)
GR (1) GR3003657T3 (xx)
HU (1) HU200919B (xx)
IL (1) IL85560A (xx)
NZ (1) NZ223670A (xx)
ZA (1) ZA881366B (xx)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU3389300A (en) 1999-03-02 2000-09-21 Merck & Co., Inc. Pyrrolidine modulators of chemokine receptor activity
AU3386400A (en) 1999-03-02 2000-09-21 Merck & Co., Inc. 3-alkyl substituted pyrrolidine modulators of chemokine receptor activity
US6362201B1 (en) 1999-03-02 2002-03-26 Merck & Co., Inc. 3-cyclopropyl and 3-cyclobutyl pyrrolidine modulators of chemokine receptor activity
TW200517114A (en) 2003-10-15 2005-06-01 Combinatorx Inc Methods and reagents for the treatment of immunoinflammatory disorders

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3301759A (en) * 1965-05-26 1967-01-31 Robins Co Inc A H Analeptic compositions and method
CA1115212A (en) * 1978-02-10 1981-12-29 Emilio Kyburz Pyrrolidine derivatives
DE3326724A1 (de) * 1983-07-25 1985-02-07 Boehringer Ingelheim KG, 6507 Ingelheim In 1-stellung substituierte 4-hydroxymethyl-pyrrolidinone, verfahren zu ihrer herstellung, pharmazeutische zusammensetzungen und zwischenprodukte
DE3336024A1 (de) * 1983-10-04 1985-04-18 Boehringer Ingelheim KG, 6507 Ingelheim 4-amino-l-benzyl-pyrrolidinone und ihre saeureadditionssalze, verfahren zu ihrer herstellung und arzneimittel

Also Published As

Publication number Publication date
US4931435A (en) 1990-06-05
HU200919B (en) 1990-09-28
JPS63238019A (ja) 1988-10-04
AU1235288A (en) 1988-09-01
HUT46535A (en) 1988-11-28
GR3003657T3 (xx) 1993-03-16
ATE71300T1 (de) 1992-01-15
ZA881366B (en) 1989-10-25
DE3867501D1 (de) 1992-02-20
AU605554B2 (en) 1991-01-17
DE3706399A1 (de) 1988-09-08
US5217967A (en) 1993-06-08
DK102988D0 (da) 1988-02-26
CA1317229C (en) 1993-05-04
EP0280290A3 (en) 1989-08-09
KR880009647A (ko) 1988-10-04
NZ223670A (en) 1990-12-21
EP0280290A2 (de) 1988-08-31
EP0280290B1 (de) 1992-01-08
DK102988A (da) 1988-08-28
IL85560A0 (en) 1988-08-31

Similar Documents

Publication Publication Date Title
EG18729A (en) Compound of n- amino - 1,2,4-triazinones used as insecticide.
EP0326196A3 (en) Aqueous pharmaceutical preparation
PL309282A1 (en) Application of 2-amino-6-n-propyl-amino- 4,5,6,7-tetrahydrobenzothiasole (pramipexol) as an antidepressant
IL128425A0 (en) Taxane derivatives their preparation and pharmaceutical compositions containing them
PH30439A (en) 3,4-Dihydro-2h-1,4-benz-oxazine derivatives and pharmaceutical compositions containing the same
IL84944A (en) Pharmaceutical compositions containing 1,2-dihydro-3h-indazolone derivatives,some new such compounds and their preparation
AU1873188A (en) Substituted 1,4-naphthoquinones as pest combatting agents
UA39101C2 (uk) ПОХІДНІ 11<font face="Symbol">b</font>-БЕНЗАЛЬДОКСИМ-ЕСТРА-4,9-ДІЄНУ, СПОСІБ ЇХ ОДЕРЖАННЯ І ФАРМАЦЕВТИЧНА КОМПОЗИЦІЯ З АНТИПРОГЕСТИНОВОЮ АКТИВНІСТЮ
ES2062375T3 (es) Composiciones farmaceuticas que contienen un complejo de zinc.
ZA9110018B (en) 2-acylamido derivatives of 3,4-dihydro-3-oxo-quinoxaline having pharmaceutical activity.
UA29435C2 (uk) Похідні 3бета-алкенілпенаму та їх фармацевтично прийнятні солі
CA2152771A1 (en) 7-o-ethers of taxane derivatives
NZ224622A (en) Benzoxepine, benzazepine and benzocycloheptene derivatives and pharmaceutical compositions
IL85560A (en) Pharmaceutical compositions containing an antidepressant of the structural type of 10,11-dihydrodibenzo(b,f)azepine,a dibenzo-(a,d)(1,4)cycloheptadiene and/or a 10,11-dihydro-benzo-(b,f)oxepine and a pyrolidinone derivative
DE3576505D1 (de) 3,4-dihydrobenzopyranverbindungen und diese enthaltende pharmazeutische zusammenstellungen.
ZA904524B (en) Dibenzo(1,5)dioxocin-5-one derivatives,their use in medicaments and processes for their preparation
NZ223521A (en) Substituted n-phenyl benzamide derivatives and anticonvulsive pharmaceutical compositions
TW218011B (xx)
ECSP920859A (es) Derivados de amonio cuaternario (-) y (+)10- (1 - azabiciclo [2.2.2] oct - 3 - il - metil) - 10 h- fenotiazina, procedimiento para obtenerlos y composiciones farmaceuticas que los contienen
NZ217356A (en) Benzamide derivatives and pharmaceutical compositions
IL85651A (en) Preparation of optically active oxo-isoindolinyl derivatives,some such novel dextrorotary isomers and pharmaceutical compositions containing the novel compounds
AR008474A1 (es) Derivado de 9-dihidroeritromicina a 6,9; 11,12-diciclocarbonato, composicion farmaceutica y preparacion bactericida que lo contienen y su uso
ES8703872A1 (es) Procedimiento para preparar derivados de isoquinolina.
IL93662A0 (en) Beta-lactam containing compounds,their preparation and pharmaceutical compositions containing them
ES2027507A6 (es) Procedimiento de preparacion de derivados selenofenicos.